Stos Partners Acquires Advanced Manufacturing/Life Sciences Building in Tustin for $19.2 Million
Stos Partners recently acquired a 71,616 square-foot advanced manufacturing/ life sciences property within the Irvine Business Complex and adjacent to Tustin Legacy from an unidentified seller for $19.2 million. The Tustin property is located at 1311 Valencia Avenue.
Microvention, a medical device manufacturing company and the current tenant, will vacate the building at the end of its lease term in March, according to Stos. Once vacant, Stos Partners plans to implement an improvement plan to upgrade the building systems and remarket the space. Seeing value in the current advanced manufacturing improvements along with the growing demand of this type of tenant in the Orange County market we believe this asset will be well positioned to secure a high quality long term tenant.
Michael Hartel, Nick Velasquez, and Grant Clancy at Colliers International represented the seller and Stos Partners in the transaction.
About Stos Partners
Stos Partners is a privately held commercial real estate investment and management firm that invests in real estate directly and in partnership with high net worth and institutional investors. With a track record spanning over one billion in transactions to date, the firm targets the most competitive risk-adjusted returns in the marketplace through opportunistic acquisitions, strategic redevelopment, and ground-up development of both institutional and small-to-mid-cap commercial properties.
Headquartered in San Diego, California with an office in Orange County, California and Laredo, Texas, Stos Partners’ local expertise and longstanding relationships translate into the ability to source, capitalize and close transactions quickly and profitably. More information is available at www.stospartners.com.